Johnson & Johnson, US4781601046

Johnson & Johnson shares, Thursday chart focus and price check

Published on 06/25/2026 at 15:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson starts Thursday with a chart-led view on the New York listing. The stock trades on the NYSE while the company sells across pharmaceuticals, medtech and consumer health.

Johnson & Johnson, US4781601046, Illustration mit AI erstellt.
Johnson & Johnson, US4781601046, Illustration mit AI erstellt.

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 13:48.

Johnson & Johnson (US4781601046) starts Thursday with a chart-led view on the New York listing. The shares trade on the NYSE, while the company remains a benchmark name in pharmaceuticals, medtech and consumer health.

The Thursday chart frame

The broader US market ended Wednesday mixed, with the S&P 500 and Nasdaq 100 falling to 1.5-week lows, according to Barchart's morning market overview. That backdrop matters for Johnson & Johnson shares on a day when investors often compare defensives with the wider index tone. Barchart market overview

Johnson & Johnson does not move in lockstep with chip stocks or the Nasdaq 100, but the index tone still shapes rotation into large healthcare names. The NYSE listing gives the stock a clear benchmark against other US mega caps.

Peer group lens

In US healthcare, Johnson & Johnson is typically read alongside Pfizer, Merck and Abbott when investors assess defensive earnings quality. That peer comparison is more relevant on a day when Barchart shows the S&P 500 and Nasdaq 100 under pressure from earlier weakness.

Reuters reported this week that US equity futures were firmer after upbeat quarterly results from Micron, a sign that broader risk appetite can shift quickly even after a mixed prior session. That is useful context for a large-cap healthcare name that often attracts steady, lower-beta flows. Reuters US market coverage

Go deeper

All news and analysis on Johnson & Johnson shares

Read more on the New York listing, market coverage and company updates tied to Johnson & Johnson.

What the company sells

Johnson & Johnson's core business still centers on pharmaceuticals, medtech and consumer health brands. The group sells well-known products such as Stelara in immunology and devices across surgery and vision care.

Where the stock trades today

Johnson & Johnson shares last traded at 0.00 USD as of 2026-06-25 13:48, because a live verified quote was not available in the provided sources.

Johnson & Johnson at a glance

  • Company: Johnson & Johnson
  • ISIN: US4781601046
  • Trading venue: NYSE
  • Price (as of 2026-06-25 13:48): 0.00 USD
  • Sector / industry: Healthcare

More on the Johnson & Johnson shares in social media

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4781601046 | JOHNSON & JOHNSON | boerse | 69624428 | bgmi